The J.M. Smucker Company
SJM
$109.02
+0.19%
The J.M. Smucker Company is a packaged food giant operating primarily in the U.S. retail channel, with a portfolio spanning coffee (Folgers, Dunkin'), pet foods (Milk-Bone, Meow Mix), frozen handhelds and spreads (Jif, Smucker's, Uncrustables), and sweet baked snacks via the Hostess acquisition. As a diversified leader in shelf-stable and frozen consumer staples, Smucker benefits from strong brand equity and deep retail distribution. The current investor narrative centers on the company's ability to drive growth through pricing actions in coffee and the integration of Hostess, while navigating margin pressures from commodity costs and a mixed demand environment—recent Q4 earnings beat on coffee pricing was tempered by a cautious sales outlook.…
SJM
The J.M. Smucker Company
$109.02
Related headlines
SJM 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The J.M. Smucker Company's 12-month outlook, with a consensus price target around $141.73 and implied upside of +30.0% versus the current price.
Average Target
$141.73
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$87 - $142
Analyst target range
SJM is covered by 6 analysts, with a consensus leaning bullish: 3 Buy/Overweight, 2 Hold, and 1 Sell (implied from ratings data). The average estimated EPS for the current fiscal year is $11.44, with a range of $10.67 to $12.09. Revenue estimates average $9.07 billion (range $8.60B–$9.47B). The average price target is not explicitly provided, but based on the forward P/E of 10.4x and average EPS of $11.44, the implied target is approximately $119.00, offering about 6.6% upside from the current price of $111.60. The consensus is moderately bullish, with several firms maintaining Overweight ratings (Wells Fargo, JP Morgan) and one upgrade to Outperform (Bernstein in March 2026).
The target range implied by the EPS estimates (low $10.67 to high $12.09) suggests a price range of roughly $111 to $126, assuming a constant forward P/E of 10.4x. The high target assumes successful margin recovery and debt reduction, while the low target prices in continued impairment risks and weak volume. Recent ratings actions show a mix: Bernstein upgraded from Market Perform to Outperform in March, while Morgan Stanley downgraded from Overweight to Equal Weight in January. The spread between high and low EPS estimates is about 13%, indicating moderate uncertainty. Overall, analyst sentiment is cautiously optimistic, but the limited coverage (6 analysts) means the stock may be less efficiently priced than larger peers.
SJM Technical Analysis
SJM is in a recovery uptrend after a sharp decline, with the stock up 6.6% over the past year but still trading at 93.5% of its 52-week range (current price $111.60 vs. 52-week high of $119.39 and low of $88.25). The price sits near the upper end of the range, suggesting positive momentum but also potential resistance as it approaches prior highs. The 1-year change of +6.6% underperforms the S&P 500's +20.6%, indicating relative weakness despite the recent bounce.
Short-term momentum is mixed: the 1-month change is -4.7% (underperforming SPY's +4.1%), while the 3-month change is a strong +22.8% (outperforming SPY's +11.1%). This divergence—a sharp 3-month rally followed by a 1-month pullback—could signal profit-taking after the run-up or a temporary consolidation before further upside. The stock's beta of 0.247 is very low, meaning it is significantly less volatile than the market, which aligns with its defensive consumer staples nature.
Key support is at the 52-week low of $88.25, while resistance is at the 52-week high of $119.39. A breakout above $119.39 would signal a new uptrend and likely attract momentum buyers, while a breakdown below $88.25 would negate the recovery and suggest further downside. With a beta of 0.247, SJM offers a low-volatility profile, making it a defensive holding but also limiting upside participation in strong markets.
Beta
0.25
0.25x market volatility
Max Drawdown
-22.8%
Largest decline past year
52-Week Range
$88-$119
Price range past year
Annual Return
+4.5%
Cumulative gain past year
| Period | SJM Return | S&P 500 |
|---|---|---|
| 1m | -6.0% | +0.0% |
| 3m | +16.1% | +7.6% |
| 6m | +6.8% | +9.1% |
| 1y | +4.5% | +21.3% |
| ytd | +12.8% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SJM Fundamental Analysis
Revenue has shown modest growth, with the most recent quarter (Q3 FY2026, ended Jan 31, 2026) reporting $2.339 billion, up 7.0% year-over-year from $2.186 billion in the prior-year quarter. However, the multi-quarter trend is uneven: Q2 FY2026 revenue was $2.330 billion (+2.6% YoY), Q1 FY2026 was $2.113 billion (-0.5% YoY), and Q4 FY2025 was $2.144 billion (-2.8% YoY). The growth is driven by pricing actions in coffee (U.S. Retail Coffee segment $1.034 billion in Q3) and the Hostess acquisition, but volume trends remain soft. The revenue trajectory is improving but still below historical growth rates, and the company's guidance suggests a cautious outlook.
Profitability is under severe pressure: net income in Q3 FY2026 was -$724 million (net margin -31.0%), compared to -$662 million in Q3 FY2025. Gross margin improved to 35.8% from 40.2% a year ago, but operating margin was 20.2% (vs. -27.2% last year) due to large impairment charges. Excluding one-time items, adjusted profitability is positive but declining. The company has reported negative GAAP net income in three of the last four quarters, largely due to non-cash impairment charges related to the Hostess acquisition. The negative GAAP earnings obscure an underlying business that generates positive operating cash flow.
The balance sheet shows elevated leverage: debt-to-equity is 1.28, and the current ratio is 0.78, indicating liquidity risk. However, free cash flow (TTM) is $971 million, providing a cushion. ROE is -2.5% (negative due to losses), but ROA is 5.1%, suggesting the asset base is generating positive returns before leverage effects. The company pays a dividend with a yield of 4.4%, but the payout ratio is negative (earnings are negative), meaning the dividend is not covered by earnings—though it is covered by free cash flow. The high debt load and negative net income raise financial risk, but strong cash flow generation provides some stability.
Quarterly Revenue
$2.3B
2026-01
Revenue YoY Growth
+7.0%
YoY Comparison
Gross Margin
35.8%
Latest Quarter
Free Cash Flow
$971200000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SJM Overvalued?
Since net income is negative (TTM net loss), the trailing P/E is not meaningful (-75.4). Therefore, we use the price-to-sales (P/S) ratio as the primary valuation metric. The trailing P/S is 1.16x, while the forward P/S (based on estimated revenue of $9.07 billion) is approximately 1.15x, implying minimal growth expectations. The EV/Sales ratio is 2.09x, reflecting the company's debt load. The forward P/E of 10.4x (based on estimated EPS of $11.44) suggests the market expects a sharp earnings recovery, but this is highly uncertain given recent impairments.
Compared to the packaged foods industry average P/S of approximately 1.5x, SJM's trailing P/S of 1.16x represents a 23% discount. This discount is likely justified by SJM's negative earnings, high debt, and sluggish organic growth. However, on a forward P/E basis, SJM's 10.4x is below the industry average of ~18x, implying a 42% discount, which could attract value investors if earnings materialize.
Historically, SJM's trailing P/S has ranged from about 1.0x to 2.5x over the past five years. The current 1.16x is near the low end of that range, suggesting the stock is cheap relative to its own history. This could indicate a value opportunity if the company can stabilize earnings and reduce debt, but it also reflects the market's skepticism about near-term fundamentals. The PEG ratio of 0.85x suggests the stock is undervalued relative to expected earnings growth, but this relies on optimistic EPS estimates.
PE
-75.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -123x~55x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.0x
Enterprise Value Multiple

